Sildenafil can affect innate and adaptive immune system in both experimental animals and patients

M Kniotek, A Boguska - Journal of immunology research, 2017 - Wiley Online Library
Sildenafil, a type 5 phosphodiesterase inhibitor (PDE5‐I), is primarily used for treating
erectile dysfunction. Sildenafil inhibits the degradation of cyclic guanosine monophosphate …

Sildenafil Can Affect Innate and Adaptive Immune System in Both Experimental Animals and Patients.

M Kniotek, A Boguska - Journal of Immunology Research, 2017 - europepmc.org
Sildenafil, a type 5 phosphodiesterase inhibitor (PDE5-I), is primarily used for treating
erectile dysfunction. Sildenafil inhibits the degradation of cyclic guanosine monophosphate …

Sildenafil Can Affect Innate and Adaptive Immune System in Both Experimental Animals and Patients

M Kniotek, A Boguska - Journal of Immunology Research, 2017 - cir.nii.ac.jp
抄録< jats: p> Sildenafil, a type 5 phosphodiesterase inhibitor (PDE5-I), is primarily used for
treating erectile dysfunction. Sildenafil inhibits the degradation of cyclic guanosine …

[PDF][PDF] Sildenafil Can Affect Innate and Adaptive Immune System in Both Experimental Animals and Patients

M Kniotek, A Boguska - 2017 - ppm.wum.edu.pl
Sildenafil, a type 5 phosphodiesterase inhibitor (PDE5-I), is primarily used for treating
erectile dysfunction. Sildenafil inhibits the degradation of cyclic guanosine monophosphate …

[PDF][PDF] Sildenafil Can Affect Innate and Adaptive Immune System in Both Experimental Animals and Patients

M Kniotek, A Boguska - 2017 - pdfs.semanticscholar.org
Sildenafil, a type 5 phosphodiesterase inhibitor (PDE5-I), is primarily used for treating
erectile dysfunction. Sildenafil inhibits the degradation of cyclic guanosine monophosphate …

Sildenafil Can Affect Innate and Adaptive Immune System in Both Experimental Animals and Patients.

M Kniotek, A Boguska - Journal of Immunology Research, 2017 - search.ebscohost.com
Sildenafil, a type 5 phosphodiesterase inhibitor (PDE5-I), is primarily used for treating
erectile dysfunction. Sildenafil inhibits the degradation of cyclic guanosine monophosphate …

Sildenafil Can Affect Innate and Adaptive Immune System in Both Experimental Animals and Patients

M Kniotek, A Boguska - Journal of immunology research, 2017 - pubmed.ncbi.nlm.nih.gov
Sildenafil, a type 5 phosphodiesterase inhibitor (PDE5-I), is primarily used for treating
erectile dysfunction. Sildenafil inhibits the degradation of cyclic guanosine monophosphate …

Sildenafil Can Affect Innate and Adaptive Immune System in Both Experimental Animals and Patients

M Kniotek, A Boguska - Journal of Immunology Research, 2017 - go.gale.com
Sildenafil, a type 5 phosphodiesterase inhibitor (PDE5-I), is primarily used for treating
erectile dysfunction. Sildenafil inhibits the degradation of cyclic guanosine monophosphate …

[HTML][HTML] Sildenafil Can Affect Innate and Adaptive Immune System in Both Experimental Animals and Patients

M Kniotek, A Boguska - Journal of Immunology Research, 2017 - ncbi.nlm.nih.gov
Sildenafil, a type 5 phosphodiesterase inhibitor (PDE5-I), is primarily used for treating
erectile dysfunction. Sildenafil inhibits the degradation of cyclic guanosine monophosphate …

Sildenafil Can Affect Innate and Adaptive Immune System in Both Experimental Animals and Patients

M Kniotek, A Boguska - Journal of Immunology Research, 2017 - search.proquest.com
Sildenafil, a type 5 phosphodiesterase inhibitor (PDE5-I), is primarily used for treating
erectile dysfunction. Sildenafil inhibits the degradation of cyclic guanosine monophosphate …